Splicing modulator antibody-drug conjugates and methods of use

MYPI2025000918A0Undetermined Publication Date: 2019-12-01EISAI R&D MANAGEMENT CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
MYPI2025000918
Authority / Receiving Office
MY · MY
Patent Type
Applications
Current Assignee / Owner
Priority Date
2018-12-13
Filing Date
2019-05-31
Publication Date
2019-12-01
Patent Text Reader

Abstract

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE ABSTRACT Linker-drug compounds and antibody-drug conjugates that bind to human oncology targets are disclosed. The linker-drug compounds and antibody-drug conjugates comprise a splicing modulator drug moiety. The disclosure further relates to methods and compositions for use in the treatment of neoplastic disorders by administering the antibody-drug conjugates provided herein.
Need to check novelty before this filing date? Find Prior Art